Why NMEs and Therapeutic Biological Products Fail in the First FDA Review Cycle. Partha Roy, Ph.D. | April 24, 2013. Positive Impact of PDUFA (1). Positive Impact of PDUFA (2). NMEs 1st cycle approval rates in the past 3 years . . . by APPROVAL Cohorts.
517 views • 40 slides
Community Clinical Oncology Program (CCOP). Role of Data Safety Monitoring Board (DSMB) Mira Shah, CIM, CCRP. March 2011. Updated: July 2006. Disclaimer.
481 views • 30 slides
Wound Healing Gel. A Silver nanoparticle based hydrogel prepared by green synthesis. Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis Social Relevance Its an OTC product with vast market potential
820 views • 21 slides
Interviewing for the Pharmaceutical Industry: what does it involve and how to succeed? David P Brooks Interviewing for Pharma The Drug Discovery & Development Process What is Pharma Looking for? Attributes Finding the open positions The Interview process Working in Industry
677 views • 20 slides
Survey of KAP of Pediatricians regarding Hib Disease & Vaccination in India during Pedicon. Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI 2011-13 email@example.com. Proposal
283 views • 15 slides
View Safety efficacy PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Safety efficacy PowerPoint presentations. You can view or download Safety efficacy presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.